Lynkuet is a Bayer prescription treatment for moderate to severe hot flashes associated with menopause. Its active ingredient is elinzanetant, and the brand’s website explains how the treatment may help reduce the number and severity of hot flashes during the day and night. The site reports that clinical studies measured efficacy at four and 12 weeks and that a reduction in hot flashes was observed as early as one week; individual results may vary. Lynkuet is taken orally once daily at bedtime.

The website offers information about hot flashes, how Lynkuet works, how to take it, safety and side effects, and patient resources. It also provides a conversation guide to help women discuss treatment options with a healthcare provider, along with access to telehealth connections. Eligible patients may find prescription savings through BlinkRx, subject to program terms and availability. Visitors can also read patient stories, submit their own experiences, and access the full prescribing and patient information.